4//SEC Filing
Rhode Peter 4
Accession 0001209191-23-058082
CIK 0001828673other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 4:56 PM ET
Size
7.4 KB
Accession
0001209191-23-058082
Insider Transaction Report
Form 4
Rhode Peter
See Remarks
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-12-11−14,000→ 22,427 totalExercise: $0.14Exp: 2029-12-19→ Common Stock (14,000 underlying) - Exercise/Conversion
Common Stock
2023-12-11$0.14/sh+14,000$1,960→ 77,500 total
Footnotes (1)
- [F1]These option shares were part of a stock option grant covering 85,713 shares of common stock. 20% of the total shares subject to the stock option grant vested on May 30, 2020; 20% of the total shares subject to the stock option grant vested on May 30, 2021; 25% of the total shares subject to the stock option grant vested on May 30, 2022; and 35% of the total shares subject to the stock option grant vested on May 30, 2023, subject to the reporting person's continuous service through the applicable vesting date.
Documents
Issuer
HCW Biologics Inc.
CIK 0001828673
Entity typeother
Related Parties
1- filerCIK 0001866276
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 4:56 PM ET
- Size
- 7.4 KB